Home > Press room > 3 questions to Christophe SICOT, Chairman and Founder of the Group

3 questions to Christophe SICOT, Chairman and Founder of the Group

A strong end to 2021 and strong prospects for development and growth in 2022 are the key messages from Christophe Sicot, Chairman and Founder of the Verso Healthcare Group, as expressed in a recent interview included in this press release.

Click here to access the press release

Articles similaires

Verso Healthcare is proud to have helped patients benefit very soon from an innovative treatment in radiotherapy

First installation in France of the ZAP-X – Verso Healthcare is proud to participate in improving the patient journey

The first installation in France of ZAP-X, the latest innovation in the treatment of malignant and benign intracranial tumors by radiosurgery, is underway at the Porte de Saint-Cloud Cancer Center. All the Verso Healthcare teams

David DESPRETZ joins the VERSO HEALTHCARE Group

To support the group’s strong commitments and growth at the international level, Verso Healthcare is pleased to announce that David DESPRETZ is joining the group as Chief Commercial Officer, reporting directly to the Group Chairman.

123CS, a subsidiary of the Verso Healthcare group, a player in healthcare cybersecurity in France and Europe

After having been awarded in 2021, the ExpertCyber label delivered by the French State, 123CS has just joined the Alliance for Digital Confidence (ACN) and obtained the ECSO Cybersecurity Made in Europe label. The Alliance

Hospitalia: Verso Healthcare and Christophe Sicot featured in the February issue on the theme 2022, ready for a new beginning?

New article on Hospitalia: 2022 has only been around for a few weeks, but it is already shaping up to be a year at the crossroads of several issues for the world of healthcare. Verso

Qualimedis and Verso Healthcare facilitate access to the ViewRay® MRIdian™ Linac system

Qualimedis and Verso Healthcare are facilitating access to ViewRay®’s MRIdian™ Linac system, the world’s first and only MRI-guided system for adaptive radiotherapy, with real-time monitoring synchronised with radiation delivery. It is a major example of

Fujifilm Healthcare France and Verso Healthcare make magnetic resonance imaging accessible to all

Although open MRI (magnetic resonance imaging) has existed for a long time, its low magnetic field, despite its advantages (absence of specific shielding, lower cost, examination of patients with prostheses, premature babies, etc.), has often

Articles

Hospitalia: Verso Healthcare and Christophe Sicot featured in the February issue on the theme 2022, ready for a new beginning?

New article on Hospitalia: 2022 has only been around for a few weeks, but it is already shaping up to be a year at the crossroads of several issues for the world of healthcare. Verso

3 questions to Christophe SICOT, Chairman and Founder of the Group

Articles similaires

First installation in France of the ZAP-X – Verso Healthcare is proud to participate in improving the patient journey

David DESPRETZ joins the VERSO HEALTHCARE Group

123CS, a subsidiary of the Verso Healthcare group, a player in healthcare cybersecurity in France and Europe

Hospitalia: Verso Healthcare and Christophe Sicot featured in the February issue on the theme 2022, ready for a new beginning?

Qualimedis and Verso Healthcare facilitate access to the ViewRay® MRIdian™ Linac system

Fujifilm Healthcare France and Verso Healthcare make magnetic resonance imaging accessible to all

Categories

Articles

First installation in France of the ZAP-X – Verso Healthcare is proud to participate in improving the patient journey

David DESPRETZ joins the VERSO HEALTHCARE Group

123CS, a subsidiary of the Verso Healthcare group, a player in healthcare cybersecurity in France and Europe

Hospitalia: Verso Healthcare and Christophe Sicot featured in the February issue on the theme 2022, ready for a new beginning?

Qualimedis and Verso Healthcare facilitate access to the ViewRay® MRIdian™ Linac system

Tags

Archives

Social